目的:探讨应用糖皮质激素对变应性鼻炎儿童皮质醇、生长激素(GH)及身高的影响.方法:变应性鼻炎患儿25例(观察组)给予布地奈德鼻喷雾剂治疗,每鼻孔1掀,2次/d,疗程4周.同时口服氯雷他定糖浆,用药剂量为0.11~0.24mg/kg,1次/d,用药4周.治疗前和治疗后6个月采静脉血5ml,采用放射免疫分析法(RIA)测定其血清皮质醇、生长激素(GH)水平,应用标准法测量并记录观察组及对照组身高.结果:观察组儿童用药前及用药6个月后其血清皮质醇和GH水平均无显著性差异.观察组身高治疗前、治疗后6个月时与对照组儿童身高比较无显著性差异.结论:糖皮质激素对变应性鼻炎儿童血清皮质醇和GH及身高的生长发育无明显影响.%Objective: To explore the changes of cortisol-growth hormone before and after corticosteroids in children with allergic rhinitis and to observe the variation of height between sick children and healthy children. Methods: Twenty-five children with allergic rhinitis were collected as observation group, and the patients were re-ceived budesonide one spray per nostril, two times per day for 4 weeks. Meanwhile these children took orally lorata dine syrup for 4 weeks. The serum blood were collected before treatment and after treatment 6 months; the contents of cortisol and growtn normone (GH) were measured by radio immunoassay(RIA). Tne heignt was measured and recorded by standard method. Results: The levels of serum cortisol and GH in children with allergic rhinitis had no significant differences before and after 6 months therapy. The height of children in observation group and control group which were healthy and had the same age and gender had no significant differences before therapy and after 6 months therapy. Conclusions:The serum consentbations of cortisol and GH in children suffered from allergis rhini tis have no obvious change before and after 6 months budesonide spray. The height changes before and after therapy nave no significant difference between observation group and control group.
展开▼